Advertisement
Advertisement

PLUR

PLUR logo

Pluri Inc. Common Stock

2.12
USD
Sponsored
+0.02
+1.19%
Jun 24, 15:59 UTC -4
Closed
exchange

After-Market

2.06

-0.06
-2.83%

PLUR Earnings Reports

Positive Surprise Ratio

PLUR beat 19 of 30 last estimates.

63%

Next Report

Date of Next Report
Sep 15, 2026
Estimate for Q4 26 (Revenue/ EPS)
$668.10K
/
-$0.67
Implied change from Q3 26 (Revenue/ EPS)
--
/
--
Implied change from Q4 25 (Revenue/ EPS)
+67.86%
/
-33.00%

Pluri Inc. Common Stock earnings per share and revenue

On May 11, 2026, PLUR reported earnings of -- USD per share (EPS) for Q3 26, -- the estimate of -0.67 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 668.10 thousand, with a --% difference.
Looking ahead to Q4 26, 3 analysts forecast an EPS of -0.67 USD, with revenue projected to reach 668.10 thousand USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
FAQ
For Q3 2026, Pluri Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Sep 15, 2026.
Based on 3 analysts, Pluri Inc. Common Stock is expected to report EPS of -$0.67 and revenue of $668.10K for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement